Kane Biotech Inc KNBIF:OTCQB

*Data is delayed | Exchange | USD
Last | 05/01/24 EDT
0.0939UNCH (UNCH)
52 week range
0.04 - 0.12
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0939
  • 52 Week High0.12
  • 52 Week High Date04/10/24
  • 52 Week Low0.04
  • 52 Week Low Date11/06/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume550
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change53.43

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0939
  • 52 Week High0.12
  • 52 Week High Date04/10/24
  • 52 Week Low0.04
  • 52 Week Low Date11/06/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume550
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change53.43

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-3.47
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kane Biotech Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB...
Philip Renaud
Chairman of the Board
Marc Edwards
President, Chief Executive Officer, Director
Raymond Dupuis
Chief Financial Officer
Lori Christofalos
Vice President - Quality & Compliance
Address
290-100 Innovation Drive
Winnipeg, MB
R3T 6G2
Canada